Licensing and collaborative opportunities for new partners

Senexis is actively seeking to enter into collaborations and licensing deals with established pharmaceutical and emerging biotechnology companies.

Out-licensing

Senexis plans to offer a balanced portfolio of pre-clinical or early clinical licensing opportunities to the pharmaceutical sector, particularly in the more costly areas of clinical development.

For further information outside Japan, please please see our main contact details here. For Japan, please contact Dr Jun Ishiguro at SC Consulting, Inc. (see below).

  Japanese Representative

 Dr Jun Ishiguro

 SC Consulting, Inc.
 9-6-13, Asumigaoka, Midori-ku,

 Chiba 267-0066 JAPAN
 TEL/FAX:+81(0)43-2295-6009 
 Email: jishiguro@sc-consultinc.com

 Web: http://www.sc-consultinc.com/